Showing results (561-570 of 941) with videos related to
Sort By:
Pageof 95
Diabetes & Vascular Disease Research|June 7, 2018
Biomarkers of vascular injury and endothelial dysfunction after recent glucose intolerance in pregnancyHarpreet S Bajaj, Chang Ye, Anthony J Hanley, et al.Diabetes & Vascular Disease Research|June 14, 2018
Evaluation of the lamina cribrosa in patients with diabetes mellitus using enhanced depth imaging spectral-domain optical coherence tomographySerkan Akkaya, Bekir Küçük, Hatice Karaköse Doğan, et al.Diabetes & Vascular Disease Research|July 10, 2018
Plasma polyunsaturated fatty acid profile is associated with vascular endothelial function in patients with type 2 diabetesTomoaki Morioka, Masanori Emoto, Satoshi Imamura, et al.Diabetes & Vascular Disease Research|April 23, 2019
A longitudinal study of choroidal changes following cataract surgery in patients with diabetesVivien Cherng-Hui Yip, Augustinus Laude, Kara Anne Tan, et al.Diabetes & Vascular Disease Research|April 26, 2019
Dipeptidyl peptidase-4 inhibitors and cardiovascular and renal disease in type 2 diabetes: What have we learned from the CARMELINA trial?Nordin Mj Hanssen, Karin Am Jandeleit-DahmDiabetes & Vascular Disease Research|November 21, 2007
Preventing type 2 diabetes and cardiovascular disease in metabolic syndrome: the role of PPARalphaJorge PlutzkyDiabetes & Vascular Disease Research|October 2, 2007
Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivityMichel Marre, Abdoulaye LeyeDiabetes & Vascular Disease Research|October 2, 2007
Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetesRobert E Ratner, Shamik Parikh, Conrad Tou, et al.Diabetes & Vascular Disease Research|October 2, 2007
Effect of glucose-insulin-potassium (GIK) infusion on biomarkers of cardiovascular risk in ST elevation myocardial infarction (STEMI): insight into the failure of GIKShailja V Parikh, Shuaib M Abdullah, Ellen C Keeley, et al.Diabetes & Vascular Disease Research|October 2, 2007
Long-term effects of pioglitazone versus gliclazide on hepatic and humoral coagulation factors in patients with type 2 diabetesGabriele Perriello, Simone Pampanelli, Paolo Brunetti, et al.Pageof 95